As Last Missouri Abortion Facility Fights to Stay Open, Ex-Workers Cite a Wider Problem, by Lauretta BrownJune 7, 2019
Survivors of the Sexual Revolution the Media Will Ignore During Gay Pride Month, by Jennifer R. MorseJune 7, 2019
By Archbishop Joseph F. Naumann, Kansas City, Kansas, Chairman of the U.S. Conference of Catholic Bishops, June 6, 2019
WASHINGTON—Yesterday, the U.S. Department of Health and Human Services announced that it will discontinue research conducted within the National Institutes of Health (NIH) involving the use of human fetal tissue from elective abortion and it will ensure that efforts to develop ethical alternatives are funded and accelerated. Archbishop Joseph F. Naumann of Kansas City, Kansas, Chairman of the U.S. Conference of Catholic Bishops’ (USCCB) Committee on Pro-Life Activities issued the following statement strongly commending the Trump Administration for this important pro-life action.
Archbishop Naumann’s full statement follows:
“We strongly commend the Trump Administration for taking actions to move our tax dollars away from research using body parts from aborted babies and toward ethical alternatives. Scavenging and commodifying the body parts of abortion victims for use in research gravely disrespects the bodies of these innocent human beings. Their remains deserve the same respect as that of any other person. To subsidize this degrading practice with our taxpayer dollars is deeply offensive to millions of Americans. Further, the use of fetal tissue procured from aborted babies also can lead to legitimizing the violence of abortion by suggesting that body parts procured in abortion are necessary for research. In truth, research using fetal tissue from aborted babies is neither ethical nor necessary. Researchers have demonstrated the ability to pursue excellence in medical research without collaborating with the abortion industry to further victimize aborted babies.”
Keywords: United States Conference of Catholic Bishops, USCCB, Abp. Joseph F. Naumann, Committee on Pro-Life Activities, Trump Administration, U.S. Department of Health and Human Services, National Institutes of Health (NIH), human fetal tissue, elective abortion, medical research, commodifying, ethical alternatives, abortion industry